Hydroxychloroquine

Category

University of Kansas Medical Center Goes All Out in Research Contributing to Beating COVID-19 and Exiting the Pandemic

University of Kansas Medical Center (KUMC) joined the ACTIV-2 clinical trial recently, targeting those patients diagnosed with mild COVID-19 symptoms in a quest to determine how the advanced monoclonal antibody-based product developed by Eli Lilly, LY-COV555, can help...

A Political Ping Pong: Duke HERO Study Still Pursuing Question Whether Hydroxychloroquine a Potential Prophylaxis to COVID-19

Meet Michael Waxman, a physician from Kansas City and participant in one of the largest hydroxychloroquine clinical trials in the United States. He also happens to have the honor of being the study’s “truest guinea pig” doing it “gladly and “without reservation.” The...

Large French Real-World Observational Study Reveals Hydroxychloroquine & Azithromycin Associated with Reduction in Hospitalization & Death for COVID-19 Patients

Led by IHU-Méditerranée Infection in Marseille, a group of French research centers initiated early and massive screening for SARS-CoV-2 (COVID-19) in a hospitalized patient demographic. The study team analyzed the treatment of hydroxychloroquine and azithromycin...

Rush Medical Center Initiates HERO-HCQ Study in Chicago: Will Hydroxychloroquine Help Protect Healthcare Workers from COVID-19?

Rush University Medical Center opened up enrollment for the HERO-HCQ clinical trial to determine whether hydroxychloroquine is better than a placebo in preventing COVID-19 in healthy people working in a health care setting. With its full title as the Healthcare Worker...

Pin It on Pinterest